The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Jun. 01, 2015
Applicant:

London Health Sciences Centre Research Inc., London, CA;

Inventor:

Eva Turley, London, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08B 37/08 (2006.01); A61K 8/73 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61Q 19/08 (2006.01); A61K 8/64 (2006.01); A61K 8/65 (2006.01); A61K 8/66 (2006.01); A61K 38/17 (2006.01); A61K 38/39 (2006.01); A61K 38/45 (2006.01); A61K 38/48 (2006.01); A61K 47/36 (2006.01); A61Q 19/00 (2006.01); A61K 47/54 (2017.01);
U.S. Cl.
CPC ...
C08B 37/0072 (2013.01); A61K 8/64 (2013.01); A61K 8/65 (2013.01); A61K 8/66 (2013.01); A61K 8/735 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 38/17 (2013.01); A61K 38/39 (2013.01); A61K 38/45 (2013.01); A61K 38/4893 (2013.01); A61K 47/36 (2013.01); A61K 47/544 (2017.08); A61Q 19/007 (2013.01); A61Q 19/08 (2013.01); C12Y 204/01212 (2013.01); C12Y 304/24069 (2013.01);
Abstract

The present invention relates to topical glycosaminoglycan compositions, particularly hyaluronan compositions, that facilitate the penetration of modified glycosaminoglycans through the skin barrier into the epidermal and dermal layers of the skin, thereby allowing for the dermal administration of a glycosaminoglycan, such as hyaluronan, without requiring an injection. Through their ability to deliver hyaluronan to the epidermal and dermal layers, the present formulations are therefore suitable for use in dermal rejuvenation, enhancement, hyaluronan replenishment and protection therapy. The glycosaminoglycan compositions are also useful as delivery devices to facilitate the dermal and transdermal delivery of cosmetically and pharmaceutically active substances, including pharmaceuticals, polypeptides, proteins and similarly sized biomacromolecules, through the skin barrier.


Find Patent Forward Citations

Loading…